Skip links

Collected once. Lifelong possibilities.

Cord tissue stem cells. A one-time opportunity.

At birth, a unique biological resource becomes available, but only for a brief moment.

Choosing to store cells from cord tissue is not about predicting the future. It is about keeping a possibility open, at a time when it is still within reach.

See your storage options

Two types of stem cells, different roles

Cord blood and cord tissue contain different types of stem cells that work in different ways in the body.

While cord blood stem cells rebuild the blood and immune system, cord tissue contains mesenchymal stem cells that support tissue repair, regulate inflammation, and interact with the immune system.

These are the same biological functions involved in many conditions families face today, which is why these cells are being studied across a growing number of clinical areas.

Powerful cells with real potential

Umbilical cord tissue contains unique stem cells that play an important role in the body’s natural processes. They have the ability to support how the body repairs, responds to inflammation, and regulates the immune system.

These are fundamental processes in many of the conditions that affect families today. In some cases, the immune system needs to be activated, while in others it needs to be reduced or carefully regulated. Throughout life, the body relies on its own stem cells to maintain and repair tissues. But the body’s ability to repair damaged tissue is limited and declines with age.

When tissue is damaged, the body cannot always fully restore it. For example, after a heart attack, the damaged area is replaced with scar tissue that cannot contract or pump blood in the same way as healthy tissue.

This is why these cells are being studied in a growing number of clinical areas.

Understand what can be stored

A one-time opportunity you cannot revisit

At birth, these cells are available only once. If they are not preserved, they are gone.

For many families, this is not about knowing what will happen, but about not missing the chance to be prepared.

Today, these cells are being studied in conditions that many people have seen up close, including:

Autoimmune conditions

Type 1 diabetes, multiple sclerosis, rheumatoid arthritis, Crohn’s disease

Neurological conditions

Cerebral palsy, autism spectrum disorders, stroke-related injury, Parkinson’s disease, Alzheimer’s disease

Orthopedic injuries

Osteoarthritis, cartilage damage, joint injuries, muscle and tendon injuries

Transplant complications

Such as graft-versus-host disease (GVHD)

Heart and vascular disease

Heart attack, heart failure, ischemic injury, vascular damage

A unique opportunity to preserve something that may hold value across a lifetime.

Not all stem cell storage is the same

Many biobanks freeze umbilical cord tissue without preparing the cells for future use.

At Cellaviva, we go further. The stem cells are isolated and characterized according to established criteria for mesenchymal stem cells (MSCs), for use in clinical studies and treatment, before being cryopreserved. They are also tested for sterility and viability prior to freezing.

This means your family does not store the raw umbilcal cord tissue, but processed and viable cells.

If the cells need to be used, time matters. Processing frozen tissue can delay access.

That difference can affect how quickly the cells can be used when it truly matters.

See how Cellaviva is different

A choice that may matter more than you think

Storing stem cells from umbilical cord tissue may be especially relevant in certain situations, but also for families who want to be prepared for the unexpected.

Mesenchymal stem cells (MSCs) from cord tissue are considered a particularly valuable cell source. They are biologically younger, have been exposed to fewer environmental factors, and have shown higher proliferative capacity in studies compared to similar cells derived from adult tissues 1, 2.

This makes them of particular interest in research related to immune regulation, inflammation, and tissue repair 3.

Situations where this may be especially relevant:

In autoimmune diseases, the body’s immune system attacks its own tissue. Stem cells are being studied for their ability to regulate immune responses and reduce inflammation in autoimmune conditions 3, 4.

If these conditions exist in your family, storing stem cells may provide access to a biological resource that could be relevant in future medical contexts.

Neurological conditions often involve inflammation and damage to the nervous system. Stem cells from cord tissue are being studied for their potential to support tissue repair and reduce inflammatory processes in neurological conditions 5, 6.

Storing stem cells at birth preserves a unique biological resource connected to your child, ensuring access to cells that are already available if needed in the future.

Storing stem cells provides an additional level of preparedness, ensuring that a valuable biological resource is preserved if medical needs arise early in life.

Most families who choose to store stem cells do so without a known medical need.

The decision is often based on the understanding that some opportunities only exist once, and that future medical needs cannot be predicted.

For many families, this is not about certainty, but about preserving an opportunity that is only available once.

Developed in a clinical environment

Cellaviva is part of NextCell Pharma, a clinical-stage company developing advanced stem cell therapies based on umbilical cord tissue.

In clinical studies, including our own, these cells have been used in the treatment of type 1 diabetes. Results show that a single treatment may preserve the body’s own insulin production and delay disease progression for several years.

This means the same type of cells stored at birth are already being used and evaluated in real clinical settings today.

This is why the way the cells are handled, prepared, and stored is critical.

One source. Many possibilities.

Stem cells from umbilical cord tissue, known as mesenchymal stem cells, are being studied for their potential use in treatments where the body’s natural ability to repair and restore tissue is not sufficient.

They can influence processes such as tissue repair, inflammation, and immune regulation, which makes them relevant across a wide range of medical applications.

Areas where these cells are being studied include:

Cartilage

Studied for the treatment of cartilage damage and joint conditions, with a focus on repair and mobility

Adipose (fat) tissue

Studied for their role in tissue repair and metabolic processes

Nerve tissue

Studied in neurological conditions and injuries where nerve function may need support

Liver tissue

Studied for their potential to support liver function and tissue repair

Trachea (windpipe)

Studied for their role in supporting airway reconstruction and function

Bone

Studied in fractures and bone injuries where regeneration and healing are needed

Muscle

Studied to support muscle repair and recovery after injury or disease

Myocardium (heart muscle)

Studied following cardiac injury, such as after a heart attack, to support tissue repair

Cornea

Studied in the treatment of eye injuries and vision-related conditions

Skin

Studied for wound healing and tissue regeneration, including burns

Together, this reflects the broad medical potential these cells represent, a potential that can only be preserved at birth.

One chance at birth. A lifetime of possibilities.

Stem cell storage is a decision you can only make once. We help you make it with confidence.

Order your Cellaviva box

References

  1. Kern, S., Eichler, H., Stoeve, J., Klüter, H., & Bieback, K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006;24(5):1294–1301. DOI:10.1634/stemcells.2005-0342
  2. Troyer, D. L., & Weiss, M. L. Wharton’s jelly-derived cells are a primitive stromal cell population. Stem Cells. 2008;26(3):591–599. DOI:10.1634/stemcells.2007-0439
  3. Uccelli, A., Moretta, L., & Pistoia, V. Mesenchymal stem cells in health and disease. Nature Reviews Immunology. 2008;8(9):726–736. DOI:10.1038/nri2395
  4. Wang, Y., Chen, X., Cao, W., & Shi, Y. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. Stem Cell Research & Therapy. 2020;11:149. DOI:10.1186/s13287-020-01638-0
  5. Sun, J. M., Song, A. W., Case, L. E., et al. Effect of autologous cord blood infusion on motor function and brain connectivity in young children with cerebral palsy. Stem Cells Translational Medicine. 2017;6(12):2071–2078. DOI:10.1002/sctm.17-0102
  6. Dawson, G., Sun, J. M., Davlantis, K. S., et al. Autologous cord blood infusions are safe and feasible in young children with autism spectrum disorder: results of a phase I open-label trial. Stem Cells Translational Medicine. 2017;6(5):1332–1339. DOI:10.1002/sctm.16-0475